A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Clinical trial NCT03811561 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03811561
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2027-11-07
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.